Related references
Note: Only part of the references are listed.A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2011)
The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury
Anita Pathil et al.
JOURNAL OF HEPATOLOGY (2011)
Tumor necrosis factor-α accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease
Wei Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
Ulrich F. H. Leuschner et al.
HEPATOLOGY (2010)
De Novo Lipogenesis and Stearoyl-CoA Desaturase Are Coordinately Regulated in the Human Adipocyte and Protect against Palmitate-induced Cell Injury
Jennifer M. Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Saturated with fat: new parspectives on lipotoxicity
Jeanne Garbarino et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Bile Salt-Phospholipid Conjugate Ursodeoxycholyl Lysophosphatidylethanolamide as a Hepatoprotective Agent
Walee Chamulitrat et al.
HEPATOLOGY (2009)
The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis
Puneet Puri et al.
HEPATOLOGY (2009)
Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
Hironori Mitsuyoshi et al.
HEPATOLOGY RESEARCH (2009)
Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model
Hiroshi Kudo et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
Steve S. Choi et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes
Sophie Clement et al.
HEPATOLOGY (2008)
Group IVA phospholipase A2 is necessary for the biogenesis of lipid droplets
Albert Gubern et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
Robert L. Wilensky et al.
NATURE MEDICINE (2008)
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Myoung Sook Han et al.
JOURNAL OF LIPID RESEARCH (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Anti-inflammatory effects of phosphatidylcholine
Irina Treede et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet
Makoto Ito et al.
HEPATOLOGY RESEARCH (2007)
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1
Gizem Rizki et al.
JOURNAL OF LIPID RESEARCH (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
K Tomita et al.
GUT (2006)
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Phosphatidylcholine homeostasis and liver failure
ZY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Role of lipoprotein-associated phospholipase A2 in atherosclerosis -: Biology, epidemiology, and possible therapeutic target
A Zalewski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
KD Lindor et al.
HEPATOLOGY (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Mitochondrial injury in steatohepatitis
D Pessayre et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease
J Araya et al.
CLINICAL SCIENCE (2004)
Nonalcoholic fatty liver disease - An underrecognized cause of cryptogenic cirrhosis
JM Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
II. Veterans affairs cooperative study of polyenylphosphatidylcholine in alcoholic liver disease
CS Lieber et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis
J George et al.
JOURNAL OF HEPATOLOGY (2003)
Bax-type apoptotic proteins porate pure lipid bilayers through a mechanism sensitive to intrinsic monolayer curvature
G Basañez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma
T Kishimoto et al.
CLINICAL BIOCHEMISTRY (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs
M Goto et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity
S Fiorucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
IA Leclercq et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
